News & Analysis on Clinical Trial Services & Contract Research And Development
Biomanufacturing demand will drive revenues for Patheon according to an Evercore ISI analyst, who has predicted the newly-listed CDMO will strengthen its capabilities through M&A.
A new system developed by MIT researchers helps ensure privacy in genomic research databases by “slightly perturbing” analysis results.
Problem at UK API plant not Italian site says GSK
An issue at a GSK API manufacturing site will limit supplies of the superbug busting antibiotic Avycaz for the next six months according to drug manufacturer Allergan.
Pfizer supplier Zhejiang Medicine Co. should quiz staff to determine the extent of data integrity deficiencies at its API plant in Xinchang, China according to the US FDA.
As regulators push the industry to adopt adaptive studies to reduce risk to both patients and manufacturers, the FDA has finalized a guidance outlining key issues and recommendations.
A year into the program, animal models of human disease could augment NIH’s Precision Medicine Initiative, say researchers.